Visit WTR Logo
Subscribe now

Valuation

$2 billion deal shows growing sophistication of drug royalty sales

Latest Royalty Pharma investment shows is further evidence of the increasing IP monetisation options open to healthcare innovators

$2 billion deal shows growing sophistication of drug royalty sales
Xiaomi royalty figures show importance of IP strategy as it grows international footprint
1 Jun 2021

Xiaomi royalty figures show importance of IP strategy as it grows international footprint

In a banner quarter, company gets off US government blacklist, grows profits, and pays a hefty royalty sum

How to calculate ROI for patent portfolios and boost corporate value
19 May 2021

How to calculate ROI for patent portfolios and boost corporate value

The Long Read: These days, both the tools and data are available to develop models for creating significant value from corporate IP assets. All too often, though, what is still missing is the will to use them. Jeremiah Chan and Jonathan Liu of Facebook and Cipher’s Nigel Swycher and Steve Harris argue that a change of mindset among portfolio managers could reap significant rewards

Latest

View all
14 May 2021

Big jury verdicts reflect significant shifts in the US patent landscape, damages experts claim

With litigation funding flooding the market and the appropriate payout for a plaintiff receiving more focus in a trial, the spate of big court awards may be set to continue Read more

12 May 2021

Australian government unveils patent box tax regime as part of upcoming budget

New scheme is aimed at encouraging biotech innovation, and follows years of industry warnings about offshoring of intellectual property Read more

7 May 2021

Samsung and Ericsson settle patent licensing dispute

Swedish company projects second quarter licensing revenues of up to $297 million after signing cross-licence which includes 5G rights Read more

30 Apr 2021

The prospect of an LG SEP sale is making some in South Korea nervous

Wireless patents are among the portfolios being shopped by the electronics giant as it withdraws from the smartphone industry – some in South Korea would prefer to keep these rights at home Read more

News

View all
22 Dec 2020

The keys to effective IP monetisation

Patent licensing is as much an art as it is a science, explain some of those featured in the new IAM Strategy 300 Global Leaders guide Read more

19 Nov 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations Read more

9 Nov 2020

Pfizer’s covid vaccine found 90% effective, but raises IP questions

Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome Read more

20 Jul 2020

After success of early stage covid-19 vaccine trial, Oxford University's coronavirus IP policy explained

With the promising news today that a coronavirus vaccine being developed by scientists at the university is safe and triggers an immune response, we revisit our exclusive April interview with the head of Oxford's tech transfer office in which he talks about its new, expedited, approach to granting covid-related licences Read more

Analysis

View all
20 Apr 2021

Large IP platform feels the heat as China scrutinises patent services

According to a recent media report, helping companies game subsidies became big business for a self-described unicorn of the IP space Read more

19 Apr 2021

European Super League could face domain and trademark issues as backlash to football revolution grows

Analysis by the team at IAM's sister publication World Trademark Review finds the 12 clubs involved are IP-savvy, but vulnerable to brand risk Read more

14 Apr 2021

How mapping IP and other intangibles can drive business value

The long read: Charting the value of intellectual assets can be difficult, writes Deloitte's Tim Heberden, but there are ways of showing their role as the drivers of revenue, efficiency and risk, and even in locating the value flows between them Read more

12 Apr 2021

Six takeaways from the $1.8 billion finale to the LG Energy Solutions - SK Innovation IP dispute

As political wrangling and potential for commercial fallout mounted, the two Korean battery suppliers reached an eleventh-hour settlement deal yesterday Read more

Insights

View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

1 Oct 2017

A round-up of IP-related quotes, observations and opinions from the recent past …

A round-up of IP-related quotes, observations and opinions from the recent past …

Read more

30 Sep 2016

McRO gives hope to US patent owners, but Section 101 uncertainty remains

After two years of uncertainty and no little gloom, a recent Federal Circuit decision may just herald the long-awaited swing-back in the pendulum that software patent owners in the United States have been waiting for. Some, though, still believe that Congress must bite the bullet and take a look at Section 101 Read more

1 Aug 2016

Brexit leaves the UPC in limbo – and that’s no bad thing

The UK vote to leave the European Union may have surprised and disappointed many in the IP community, but a rush to bypass the decision and implement the unitary patent package would be a mistake

Read more

Trending

1

Xiaomi royalty figures show importance of IP strategy as it grows international footprint

2

From French fancy to global community – celebrating 100 issues of IAM 

3

A rotten Apple standard

4

How to value a professional services firm in an M&A transaction

5

Buying strategies for growing companies; the great "troll" debate; US hope & more at IPBC Asia 2015 Day Two

Find an expert

Daniel M McGavock
Vice President
Chicago IL, United States
Charles River Associates
View full biography